Aavogen Revenue

Biotechnology Research • Rockville, Maryland, United States • 1-10 Employees

Aavogen revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	$675,000

Key Contact at Aavogen

Buel Rodgers

Founder & Chief Executive Officer

Company overview

Headquarters	Rockville, Maryland, United States
Website	aavogen.com
NAICS	541714
SIC	873
Keywords	Regenerative Medicine, Gene Therapy, Muscular Dystrophy, Muscle Biology, Cachexia
Founded	2015
Employees	1-10
Socials

About Aavogen

Biotech startup that develops gene therapeutics for muscle wasting diseases. This includes inclusion body myositis, muscular dystrophies, peripheral nerve damage and more. At Aavogen, we make you stronger!

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Aavogen has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Aavogen's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-11-01	3	$400,000
2023-09-01	9	$275,000

Funding Insights

$675,000

Total funding amount

$275,000

Most recent funding amount

Number of funding rounds

Aavogen Tech Stack

Discover the technologies and tools that power Aavogen's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Twitter Emoji

Font scripts

GoDaddy Lyrical

WordPress themes

jQuery

JavaScript libraries

GoDaddy

Hosting

HTTP/3

Miscellaneous

PHP

Programming languages

HSTS

Security

WordPress

Blogs

MySQL

Databases

Beaver Builder

WordPress plugins

RSS

Miscellaneous

Frequently asked questions

Aavogen is located in Rockville, Maryland, US.

Aavogen generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.

Aavogen has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Aavogen was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Aavogen has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Aavogen has raised a total of $675,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Aavogen

Buel Rodgers

Founder & Chief Executive Officer

4.8

40,000 users